SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis
Not yet recruiting
Takeda Pharmaceuticals North America, Inc.
Phase 3
2021-12-01
The purpose of the aPCC-emicizumab safety study is to prospectively investigate the safety
and hemostatic efficacy of a personalized dose of aPCC in children and adults with hemophilia
A and inhibitors on emicizumab prophylaxis during acute bleeding events or prior to
procedures.
SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis
Not yet recruiting
Emory University
Phase 3
2021-12-01
The purpose of the aPCC-emicizumab safety study is to prospectively investigate the safety
and hemostatic efficacy of a personalized dose of aPCC in children and adults with hemophilia
A and inhibitors on emicizumab prophylaxis during acute bleeding events or prior to
procedures.
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
Recruiting
LFB USA, Inc.
Phase 4
2021-06-28
Phase IV multi-center, US-centric, open-label, safety study enrolling participants with
Hemophilia A or B with inhibitors aged 12 to 65 years, inclusive, who are either on long term
prophylactic treatment (e.g., emicizumab) at risk of experiencing a breakthrough bleeding
event (BE), or who are not on prophylactic treatment who may need to control a BE.
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
Recruiting
American Thrombosis and Hemostasis Network
Phase 4
2021-06-28
Phase IV multi-center, US-centric, open-label, safety study enrolling participants with
Hemophilia A or B with inhibitors aged 12 to 65 years, inclusive, who are either on long term
prophylactic treatment (e.g., emicizumab) at risk of experiencing a breakthrough bleeding
event (BE), or who are not on prophylactic treatment who may need to control a BE.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.